BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
- PMID: 30356583
- PMCID: PMC6188930
- DOI: 10.1016/j.jshs.2016.10.004
BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
References
-
- Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735–741. - PubMed
-
- Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 1999;402:533–537. - PubMed
-
- Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402:537–540. - PubMed
-
- Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci. 1999;14:419–427. - PubMed
LinkOut - more resources
Full Text Sources